xtandi
astellas pharma europe b.v. - enzalutamid - nowotwory stercza - terapia endokrynologiczna - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
citocartin 100 (40 mg + 10 mcg)/ml roztwór do wstrzykiwań
molteni dental s.r.l. - articaini hydrochloridum + adrenalinum - roztwór do wstrzykiwań - (40 mg + 10 mcg)/ml
anapran 275 mg tabletki powlekane
adamed pharma s.a. - naproxenum natricum - tabletki powlekane - 275 mg
anapran 550 mg tabletki powlekane
adamed pharma s.a. - naproxenum natricum - tabletki powlekane - 550 mg
isoptin 40 40 mg tabletki powlekane
viatris healthcare sp. z o.o. - verapamili hydrochloridum - tabletki powlekane - 40 mg
chloropernazinum 10 mg tabletki
labor przedsiębiorstwo farmaceutyczno-chemiczne sp. z o.o. - prochlorperazini dimaleas - tabletki - 10 mg
eltroxin 100 mcg tabletki
aspen pharma trading ltd. - levothyroxinum natricum - tabletki - 100 mcg
dobutamin sandoz 250 mg proszek do sporządzania roztworu do infuzji
sandoz gmbh - dobutamini hydrochloridum - proszek do sporządzania roztworu do infuzji - 250 mg
eltroxin 50 mcg tabletki
aspen pharma trading ltd. - levothyroxinum natricum - tabletki - 50 mcg
dopaminum hydrochloricum wzf 1% 10 mg/ml roztwór do infuzji
zakłady farmaceutyczne polpharma s.a. - dopamini hydrochloridum - roztwór do infuzji - 10 mg/ml